PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 25 No. 7
Pages: 1  2  3  4  
Previous Next
 

Addiction Research and Treatment

By Lisa J. Merlo, PhD and Mark S. Gold, MD | June 1, 2008
Dr Merlo is assistant professor in the department of psychiatry, division of addiction medicine, at the University of Florida in Gainsville. Dr Gold is Donald Dizney Eminent Scholar, distinguished professor, and chair of the department of psychiatry at the McKnight Brain Institute, departments of psychiatry, neuroscience, anesthesiology, and community health and family medicine, at the University of Florida. The authors report no conflicts of interest concerning the subject matter of this article.

Pharmacotherapy

Building on the findings related to neurobiological influences in addiction and the importance of managing relapse, investigators have developed several pharmacological interventions to manage the symptoms of intoxication and withdrawal, as well as to control cravings. For example, the introduction of naloxone(Drug information on naloxone), an opioid antagonist, as an emergency intervention for narcotic overdose has saved countless lives.30

The next major advance occurred when clonidine(Drug information on clonidine) (an a2-adrenergic agonist) was identified as a nonopiate treatment to reverse the effects of opiate withdrawal.31 Building on this finding, treatment with naltrexone(Drug information on naltrexone) (a pure opioid antagonist) following clonidine therapy was introduced to assist with rapid drug detoxification and to offer an alternative to methadone(Drug information on methadone) maintenance therapy.32 Methadone maintenance therapy and buprenorphine(Drug information on buprenorphine) therapy continue to assist individuals in managing symptoms of withdrawal to overcome opiate addiction; however, the advances in detoxification methods allow individuals the opportunity to live drug free.

More recently, injectable naltrexone has been approved to help individuals who struggle with adherence to daily treatment. In addition, acamprosate(Drug information on acamprosate) (a GABA agonist/glutamate antagonist) has been shown to be efficacious in reducing alcohol(Drug information on alcohol) consumption in persons with alcohol dependence, without adverse effects.33 However, in a recent study, naltrexone and/or behavioral therapy were found to be more efficacious than treatment with acamprosate or placebo.34 Varenicline(Drug information on varenicline), a partial nicotine(Drug information on nicotine) agonist, has been approved to treat nicotine dependence by combating withdrawal symptoms and blocking the effects of nicotine. Unfortunately, no pharmacological treatments for cocaine yet exist, and prevention remains the best treatment.

Behavioral treatments

Many persons with substance abuse actually choose to change their behavior on their own.35 However, for those who are not ready to change, motivational interviewing approaches may help.36 Motivational interviewing is a brief, patient-centered, directive approach that emphasizes personal choice and responsibility. It has demonstrated efficacy with addiction populations related to both quitting/cutting down on substance use or accepting formal treatment. In addition, research has shown that contingency management techniques, most notably voucher-based reinforcement therapy, can help patients achieve abstinence from various substances of abuse including cocaine and other stimulants, opioids, marijuana, tobacco, and alcohol.37 Voucher-based reinforcement therapy has also shown efficacy in promoting adherence to pharmacotherapy, psycho- therapy, and other support services

Cognitive-behavioral therapy (CBT) is a relatively brief treatment approach that often serves as the foundation of psychosocial intervention for patients with addictions. CBT typically combines psychoeducation, functional analysis, skill-building, environmental modification and contingency management, examination of dysfunctional thinking, coping skills training, and other techniques. The therapist will teach and encourage more adaptive thinking, work with the patient to address barriers to sobriety, teach alternative coping strategies, and assist the patient to identify and elicit social support. Marital and/or family therapy may also be used to augment other interventions in order to decrease environmental conflict and improve support, because this is generally associated with greater success in maintaining recovery.38

12-Step programs

Participation in a 12-step program (eg, Alcoholics or Narcotics Anonymous, Double Trouble in Recovery) is beneficial for many individuals with an addiction disorder.39 Although some individuals are hesitant to join these groups, psychiatrists can assist these patients through "12-step facilitation."40 This approach involves providing psychoeducation and focusing on 3 core topics:

  • Introducing the patient to the 12-step philosophy.
  • Working with the patient to complete the first 3 steps.
  • Encouraging the patient to become actively involved in a 12-step program.

Alcoholics Anonymous is currently the most popular mutual-help group for Americans with alcohol addiction, but even those with dual diagnosis benefit from participation in a 12-step program.41 Indeed, participation in a 12-step program is associated with increased self-efficacy for abstinence and spirituality.42 Participants who help others show lower rates of relapse, and most participants in the later stages of recovery continue to help other addicts.42,43

 

Drug testing

Research and clinical experience also demonstrate the utility of random drug testing as both a preventive tool and a component of treatment for patients with chemical addictions. Although many clinicians rely on self-reports or collateral reports, because of improved accuracy, urine screening is generally viewed as the preferred method for assessing substance use.44 It is also more sensitive and less invasive than blood testing, and it can be augmented by hair testing (for some drugs) to assess for drug use over long periods. Negative findings on drug testing are a common outcome measure in addiction research and an essential component of recovery according to the Betty Ford Institute Consensus Panel.45 When alcohol is the drug of abuse, urine screening for ethyl glucuronide may provide a more sensitive assessment than blood or breath tests.46 Drug testing does not provide information regarding levels of impairment or presence of an addiction; rather, results indicate whether the drug was recently used by the individual.

Pages: 1  2  3  4  
Previous Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





Evidence-Based References
• Betty Ford Institute Consensus Panel. What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat. 2007;33:221-228.
• Fowler JS, Volkow ND, Kassed CA, Chang L. Imaging the addicted human brain. Sci Pract Perspect. 2007; 3: 4-16.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • An Update on ADHD
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Ethical and Legal Issues in Geriatric Psychiatry
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy